DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

LTM Limited — Press Release

NSE 58 min ago·5 Oct 2026, 5:38 am

LTM

LTM Limited has announced the launch of its new product, AgenTraceIQ, under the BlueVerse platform. This development was disclosed in a press release sent to the stock exchange. The company is integrating this new solution into its existing portfolio of offerings.

For investors, this news highlights LTM's continued efforts to innovate and expand its service capabilities. The launch of AgenTraceIQ could potentially attract new clients or strengthen the company's position in its target market. It signals a focus on technological advancement within the business.

Investors should monitor the market reception to this new product and any subsequent updates from the company regarding its adoption. Keeping an eye on LTM's quarterly results will be key to understanding the long-term impact of this strategic move.